ConductScience.org, home

Paper33348673

The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction.

Campelj DG and 5 others. Cancers (Basel), 2020. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction. Papers, record 33348673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33348673

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.64
iCite
Revised in PubMed
2020-12-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Campelj DGDean G
2Timpani CACara Ahttps://orcid.org/0000-0003-4567-4319
3Petersen ACAaron Chttps://orcid.org/0000-0003-1508-748X
4Hayes AAlanhttps://orcid.org/0000-0003-1398-3694
5Goodman CACraig Ahttps://orcid.org/0000-0002-5874-7743
6Rybalka EEmmahttps://orcid.org/0000-0002-4854-0036

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131968693Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome.Molecules2020https://conductscience.org/library/papers/31968693PubMed
223530101Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.J Clin Oncol2013https://conductscience.org/library/papers/23530101PubMed
332069876Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies.Int J Mol Sci2020https://conductscience.org/library/papers/32069876PubMed
424442322The role of mTORC1 in regulating protein synthesis and skeletal muscle mass in response to various mechanical stimuli.Rev Physiol Biochem Pharmacol2014https://conductscience.org/library/papers/24442322PubMed
517470860
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
J Clin Oncol2007https://conductscience.org/library/papers/17470860PubMed
632393676The flipside of the TOR coin - TORC2 and plasma membrane homeostasis at a glance.J Cell Sci2020https://conductscience.org/library/papers/32393676PubMed
729520731Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.Clin Pharmacokinet2018https://conductscience.org/library/papers/29520731PubMed
87867226Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.Clin Exp Pharmacol Physiol1994https://conductscience.org/library/papers/7867226PubMed
922495301Hsp72 preserves muscle function and slows progression of severe muscular dystrophy.Nature2012https://conductscience.org/library/papers/22495301PubMed
106087973Protein synthesis in muscle measured in vivo in cachectic patients with cancer.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6087973PubMed
1129089584ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.Sci Rep2017https://conductscience.org/library/papers/29089584PubMed
1226909043YAP-Mediated Mechanotransduction in Skeletal Muscle.Front Physiol2016https://conductscience.org/library/papers/26909043PubMed
1327167634Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?Cancer Chemother Pharmacol2016https://conductscience.org/library/papers/27167634PubMed
1427807421Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways.Front Physiol2016https://conductscience.org/library/papers/27807421PubMed
1531241984Distribution and activation of matrix metalloproteinase-2 in skeletal muscle fibers.Am J Physiol Cell Physiol2019https://conductscience.org/library/papers/31241984PubMed
1632265741Skeletal Muscle Extracellular Matrix - What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review.Front Physiol2020https://conductscience.org/library/papers/32265741PubMed
1729991992Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia.Eur J Transl Myol2018https://conductscience.org/library/papers/29991992PubMed
1821296615Definition and classification of cancer cachexia: an international consensus.Lancet Oncol2011https://conductscience.org/library/papers/21296615PubMed
1930870215Resistance Exercise-Induced Hypertrophy: A Potential Role for Rapamycin-Insensitive mTOR.Exerc Sport Sci Rev2019https://conductscience.org/library/papers/30870215PubMed
2021960318First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.J Cancer Res Clin Oncol2012https://conductscience.org/library/papers/21960318PubMed

See all 103 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
40790174Promoting mitochondrial fusion is protective against cancer-induced muscle detriments in males and females.BMC Cancer2025https://conductscience.org/library/papers/40790174PubMed
40604314The role of NAD+ metabolism and its modulation of mitochondria in aging and disease.NPJ Metab Health Dis2025https://conductscience.org/library/papers/40604314PubMed
40468964Haptoglobin and Glutamine Synthetase May Biomark Cachexia Induced by Antiacute Myeloid Leukaemia Chemotherapy.J Cachexia Sarcopenia Muscle2025https://conductscience.org/library/papers/40468964PubMed
40381228Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy.Redox Biol2025https://conductscience.org/library/papers/40381228PubMed
39001580Dystrophin S3059 phosphorylation partially attenuates denervation atrophy in mouse tibialis anterior muscles.Physiol Rep2024https://conductscience.org/library/papers/39001580PubMed
38321934Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation.Nucleic Acids Res2024https://conductscience.org/library/papers/38321934PubMed
37751291Dimethyl fumarate modulates the dystrophic disease program following short-term treatment.JCI Insight2023https://conductscience.org/library/papers/37751291PubMed
34298829Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere.Cancers (Basel)2021https://conductscience.org/library/papers/34298829PubMed
34067869Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34067869PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EIF2S11965PubTator's text mininghttps://conductscience.org/library/genes/1965NCBI Gene
FBXO32114907PubTator's text mininghttps://conductscience.org/library/genes/114907NCBI Gene
PARP1142PubTator's text mininghttps://conductscience.org/library/genes/142NCBI Gene
TRIM6384676PubTator's text mininghttps://conductscience.org/library/genes/84676NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33348673

GET https://conductscience.org/api/papers/v1/33348673/references?page=2